Ning Na, He Kai, Wang Yanzhi, Zou Zongyao, Wu Hao, Li Xuegang, Ye Xiaoli
School of Pharmaceutical Sciences, Southwest University, Chongqing, China; Engineer Research Center of Chongqing Pharmaceutical Process and Quality Control, Chongqing, China; Department of Pharmacy, Tongren Polytechnic College, Tongren, Guizhou, China.
Phytother Res. 2015 May;29(5):668-73. doi: 10.1002/ptr.5295. Epub 2015 Jan 14.
Palmatine (PAL) is one of the main alkaloids in Coptis chinensis. The present aim was to investigate the hypolipidemic effect and mechanism of palmatine in hamsters fed with high-fat diet (HFD). PAL treatment decreased serum total cholesterol (TC), triglyceride (TG), and low-density lipoprotein cholesterol (LDL-C) levels, as well as increased fecal excretion of TC and total bile acids (TBA) in hyperlipidemic hamsters. Furthermore, PAL treatment up-regulated low-density lipoprotein receptor (LDLR) and cholesterol 7α-hydroxylase (CYP7A1) mRNA and protein expression and down-regulated apical sodium-dependent bile salt transporter (ASBT) mRNA and protein expression. These results demonstrated that PAL as a potential natural cholesterol lowering agent works by up-regulating LDLR and CYP7A1 mRNA and protein expression, down-regulating ASBT mRNA and protein expression, as well as enhancing fecal excretion of TC and TBA. The findings in our study suggest that palmatine could be a potential natural agent for treating hyperlipidemia.
巴马汀(PAL)是黄连中的主要生物碱之一。目前的目的是研究巴马汀对高脂饮食(HFD)喂养的仓鼠的降血脂作用及其机制。巴马汀治疗可降低高脂血症仓鼠的血清总胆固醇(TC)、甘油三酯(TG)和低密度脂蛋白胆固醇(LDL-C)水平,并增加粪便中TC和总胆汁酸(TBA)的排泄。此外,巴马汀治疗上调了低密度脂蛋白受体(LDLR)和胆固醇7α-羟化酶(CYP7A1)的mRNA和蛋白表达,下调了顶端钠依赖性胆汁盐转运体(ASBT)的mRNA和蛋白表达。这些结果表明,巴马汀作为一种潜在的天然降胆固醇药物,通过上调LDLR和CYP7A1的mRNA和蛋白表达、下调ASBT的mRNA和蛋白表达以及增强粪便中TC和TBA的排泄来发挥作用。我们研究中的发现表明,巴马汀可能是一种治疗高脂血症的潜在天然药物。